Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $136.2 million.

  • Acadia Healthcare Company's Capital Expenditures fell 2838.53% to $136.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $682.1 million, marking a year-over-year increase of 903.06%. This contributed to the annual value of $690.4 million for FY2024, which is 6277.56% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Capital Expenditures of $136.2 million as of Q3 2025, which was down 2838.53% from $167.7 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Capital Expenditures high stood at $203.5 million for Q4 2024, and its period low was $43.7 million during Q3 2021.
  • In the last 5 years, Acadia Healthcare Company's Capital Expenditures had a median value of $90.8 million in 2023 and averaged $112.3 million.
  • As far as peak fluctuations go, Acadia Healthcare Company's Capital Expenditures surged by 11406.99% in 2024, and later tumbled by 2838.53% in 2025.
  • Over the past 5 years, Acadia Healthcare Company's Capital Expenditures (Quarter) stood at $88.2 million in 2021, then dropped by 0.94% to $87.4 million in 2022, then skyrocketed by 58.8% to $138.7 million in 2023, then skyrocketed by 46.69% to $203.5 million in 2024, then tumbled by 33.05% to $136.2 million in 2025.
  • Its last three reported values are $136.2 million in Q3 2025, $167.7 million for Q2 2025, and $174.6 million during Q1 2025.